DOCSLIB.ORG

The Human Microbiome Project: Getting to the Guts of the Matter in Cancer Epidemiology

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Human Microbiome Project: Getting to the Guts of the Matter in Cancer Epidemiology 2523 Editorial The Human Microbiome Project: Getting to the Guts of the Matter in Cancer Epidemiology Johanna W. Lampe Cancer Prevention Program, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center and Department of Epidemiology, University of Washington, Seattle, Washington With the completion of the Human Genome Project, we A growing body of evidence suggests an important have a new array of tools to carry out genetic role of the gut microbiota in relation to the risk of cancer. epidemiologic studies. Thanks to the Human Micro- Chronic gastric inflammation caused by Helicobacter biome Project (1), launched recently by the NIH Road- pylori infection and chronic intestinal inflammation map for Medical Research, we will be in a position to associated with a dysregulated immune response to expand our understanding of the human genetic land- commensal bacteria in inflammatory bowel disease are scape to include the microbes that reside in and on the established risk factors for gastric and colon cancers, human body and contribute to human health and respectively (5). Although, to date, much of the focus on disease. Microorganisms make up only 1% to 2% of the the gut microbes has been on their relationship to mass of the body of a healthy human, but microbial cells gastrointestinal malignancies, their capacity to influence are estimated to outnumber human cells by 10 to 1 and inflammation and other downstream pathways system- the number of microbial genes (i.e., the microbiome) is ically (6) suggests the potential for a farther reaching suggested to outnumber human genes by 100 to 1. effect of the gut microbial community on the risk of Whereas it is recognized that microbes play major roles cancer in other tissues, too. Examples of functional in maintaining health and causing illness, relatively contributions of the gut microbiota that may influence little is known about the role that microbial communities cancer susceptibility in the broader sense include the play in human health and disease and how they harvest of otherwise inaccessible nutrients and/or influence human development, physiology, immunity, sources of energy from the diet, metabolism of xeno- and nutrition. biotics (i.e., dietary constituents, drugs, etc.), renewal of The majority of microbes that colonize humans live gut epithelial cells, and development and activity of the in the distal gut. Traditional medical microbiology immune system (7). has typically focused on the study of individual species The mission of the Human Microbiome Project is to as isolated, culturable units, and for good reason, parti- generate resources to enable a comprehensive character- cularly on pathogens. However, the gut is a complex ization of the human microbiota and analysis of its role in ecosystem of microbial communities. Advances in DNA human health and disease. Broadly, the project has set sequencing technologies and other molecular techniques the following goals: determining whether individuals have allowed for more comprehensive examination of share a core human microbiome; understanding whether microbial communities and have revealed that more than changes in the human microbiome can be correlated with 80% of gut bacterial species are refractory to culturing changes in human health; developing the new techno- methods. The 16S rRNA gene, present in all microbes, is a logical and bioinformatic tools needed to support these useful tool for characterizing gut microbial community goals; and addressing the ethical, legal, and social structure, in that it has enough sequence conservation implications raised by human microbiome research (1). for accurate alignment but enough variation for phylo- To this end, sequencing is a primary focus of the Human genetic analyses. There are an estimated 500 to 1,000 Microbiome Project. Initially, researchers will sequence species and over 7,000 strains in the human gut (2). Fecal 600 microbial genomes, completing a collection that will bacterial profiles are representative of interindividual include f1,000 microbial genomes and which can differences in gut microbial communities, with the diffe- contribute toward a reference microbiome data set. This rences between individuals being greater than the differ- will be expanded to a metagenomic approach using ences between different sampling sites within an whole genome shotgun sequencing in order to provide individual (3). Further, microbial community structure has insights into functional pathways present in the human been shown to be stable over a period of at least a year (4). microbiome. On the heels of this initial work will come the need for observational epidemiologic studies to characterize the variability in ‘‘normal conditions,’’ and Cancer Epidemiol Biomarkers Prev 2008;17(10):2523 – 2 ultimately disease predisposition and pathogenesis (7). Received 8/20/08; accepted 8/26/08. In molecular epidemiologic studies of cancer risk, we Requests for reprints: Johanna W. Lampe, Fred Hutchinson Cancer Research Center, can interrogate the human genome retrospectively using P.O. Box 19024, M4-B402, 1100 Fairview Avenue North, Seattle, WA 98109. Phone: 206-667-6580; Fax: 206-667-7850. E-mail: [email protected] case-control designs. Unfortunately, the same probably Copyright D 2008 American Association for Cancer Research. cannot be said for characterizing the relationship doi:10.1158/1055-9965.EPI-08-0792 between the gut bacterial genome and cancer risk. The Cancer Epidemiol Biomarkers Prev 2008;17(10). October 2008 Downloaded from cebp.aacrjournals.org on September 23, 2021. © 2008 American Association for Cancer Research. 2524 Guts of the Matter: The Human Microbiome Project interindividual variability in the gut microbiome is fecal samples from well-characterized, population-based influenced by host physiology, pathobiology, environ- cohorts will provide the necessary resource to contribute ment, and lifestyle. Consequently, as for exposure to the ultimate goals of the Human Microbiome Project biomarkers, case-control designs are not appropriate, and the opportunity to understand the role of the gut because the disease itself, the symptoms of the disease, microbiome in cancer susceptibility and the etiology of and its therapy all have the potential to alter gut specific cancers. Elucidating the complex interplay of the microbial composition. Further, changes in the micro- gut microbiome, host genetics, and environmental biome may precede the development of, or even exposures may help to guide future cancer prevention contribute to, the emergence of factors related to cancer strategies. susceptibility. For example, higher numbers of Firmicutes Bacteroidetes and fewer in the gut have been associated Disclosure of Potential Conflicts of Interest with increased energy storage and obesity in humans (4) and a small, prospective study in children suggests that No potential conflicts of interest were disclosed. aberrant compositional development of the gut micro- biota may precede becoming overweight (8). A prospective approach, using population-based References cohort studies, is going to be necessary to characterize 1. NIH Roadmap for Medical Research Human Microbiome Project. Bethesda (MD): Office of Portfolio Analysis and Strategic Initiatives, the impact of the gut bacterial community on cancer risk. National Institutes of Health. Page last reviewed: 2008 Jul 24, Unfortunately, to date, few cohort studies include the accessed 2008 Aug 20. Available from: http://nihroadmap.nih.gov/ collection of fecal samples. To quote Taro Gomi, author hmp/. of several beloved children’s books, ‘‘Everyone poops.’’ 2. Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006;124: (9). In that regard, there is plenty of sample available, 837 – 48. and as long as we establish sampling approaches that 3. Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human make it easy for participants to collect fecal aliquots and intestinal microbial flora. Science 2005;308:1635 – 8. that preserve the microbial DNA and RNA in the fecal 4. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature 2006;444:1022 – 3. sample, we have the capacity to develop an invaluable 5. Fukata M, Abreu MT. Role of Toll-like receptors in gastrointestinal resource. Application of the new molecular techniques malignancies. Oncogene 2008;27:234 – 43. for characterizing the gut microbiome has meant that the 6. Cani PD, Bibiloni R, Knauf C, et al. Changes in gut microbiota control previous logistical nightmares of immediate delivery of metabolic endotoxemia-induced inflammation in high-fat diet- induced obesity and diabetes in mice. Diabetes 2008;57:1470 – 81. fecal samples to the laboratory for culturing are no longer 7. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight an issue, and the storage of samples for nested case- R, Gordon JI. The human microbiome project. Nature 2007;449: control studies is an option. 804 – 10. In summary, achieving the mission of the Human 8. Kallioma¨ki M, Collado MC, Salminen S, Isolauri E. Early differences in fecal microbiota composition in children may predict overweight. Microbiome Project is going to require the collaborative Am J Clin Nutr 2008;87:534 – 8. effort of investigators from a wide range of disciplines, 9. Gomi T. Everyone poops. La Jolla (CA): Kane/Miller Book including epidemiology. Establishing repositories of Publishers; 1993. Cancer Epidemiol
Load more

Recommended publications
  • The Gut Microbiota and Inflammation
    International Journal of Environmental Research and Public Health Review The Gut Microbiota and Inflammation: An Overview 1, 2 1, 1, , Zahraa Al Bander *, Marloes Dekker Nitert , Aya Mousa y and Negar Naderpoor * y 1 Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Melbourne 3168, Australia; [email protected] 2 School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane 4072, Australia; [email protected] * Correspondence: [email protected] (Z.A.B.); [email protected] (N.N.); Tel.: +61-38-572-2896 (N.N.) These authors contributed equally to this work. y Received: 10 September 2020; Accepted: 15 October 2020; Published: 19 October 2020 Abstract: The gut microbiota encompasses a diverse community of bacteria that carry out various functions influencing the overall health of the host. These comprise nutrient metabolism, immune system regulation and natural defence against infection. The presence of certain bacteria is associated with inflammatory molecules that may bring about inflammation in various body tissues. Inflammation underlies many chronic multisystem conditions including obesity, atherosclerosis, type 2 diabetes mellitus and inflammatory bowel disease. Inflammation may be triggered by structural components of the bacteria which can result in a cascade of inflammatory pathways involving interleukins and other cytokines. Similarly, by-products of metabolic processes in bacteria, including some short-chain fatty acids, can play a role in inhibiting inflammatory processes. In this review, we aimed to provide an overview of the relationship between the gut microbiota and inflammatory molecules and to highlight relevant knowledge gaps in this field.
    [Show full text]
  • Contribution of the Human Microbiome and Proteus Mirabilis to Onset and Progression of Rheumatoid Arthritis: Potential for Targeted Therapy
    Internet Journal of Allied Health Sciences and Practice Volume 19 Number 3 Article 6 2021 Contribution of the Human Microbiome and Proteus mirabilis to Onset and Progression of Rheumatoid Arthritis: Potential for Targeted Therapy Jessica Kerpez Nova Southeastern University, [email protected] Marc Kesselman Nova Southeastern University, [email protected] Michelle Demory Beckler Nova Southeastern University, [email protected] Follow this and additional works at: https://nsuworks.nova.edu/ijahsp Part of the Genetic Phenomena Commons, Genetic Processes Commons, Immune System Diseases Commons, Medical Biochemistry Commons, and the Musculoskeletal Diseases Commons Recommended Citation Kerpez J, Kesselman M, Demory Beckler M. Contribution of the Human Microbiome and Proteus mirabilis to Onset and Progression of Rheumatoid Arthritis: Potential for Targeted Therapy. The Internet Journal of Allied Health Sciences and Practice. 2021 Jan 01;19(3), Article 6. This Review Article is brought to you for free and open access by the College of Health Care Sciences at NSUWorks. It has been accepted for inclusion in Internet Journal of Allied Health Sciences and Practice by an authorized editor of NSUWorks. For more information, please contact [email protected]. Contribution of the Human Microbiome and Proteus mirabilis to Onset and Progression of Rheumatoid Arthritis: Potential for Targeted Therapy Abstract The human microbiome has been shown to play a role in the regulation of human health, behavior, and disease. Data suggests that microorganisms that co-evolved within humans have an enhanced ability to prevent the development of a large spectrum of immune-related disorders but may also lead to the onset of conditions when homeostasis is disrupted.
    [Show full text]
  • Health Impact and Therapeutic Manipulation of the Gut Microbiome
    Review Health Impact and Therapeutic Manipulation of the Gut Microbiome Eric Banan-Mwine Daliri 1 , Fred Kwame Ofosu 1 , Ramachandran Chelliah 1, Byong Hoon Lee 2,3,* and Deog-Hwan Oh 1 1 Department of Food Science and Biotechnology, Kangwon National University, Chuncheon 200-701, Korea; [email protected] (E.B.-M.D.); [email protected] (F.K.O.); [email protected] (R.C.); [email protected] (D.-H.O.) 2 Department of Microbiology/Immunology, McGill University, Montreal, QC H3A 2B4, Canada 3 SportBiomics, Sacramento Inc., Sacramento, CA 95660, USA * Correspondence: [email protected] Received: 24 March 2020; Accepted: 19 July 2020; Published: 29 July 2020 Abstract: Recent advances in microbiome studies have revealed much information about how the gut virome, mycobiome, and gut bacteria influence health and disease. Over the years, many studies have reported associations between the gut microflora under different pathological conditions. However, information about the role of gut metabolites and the mechanisms by which the gut microbiota affect health and disease does not provide enough evidence. Recent advances in next-generation sequencing and metabolomics coupled with large, randomized clinical trials are helping scientists to understand whether gut dysbiosis precedes pathology or gut dysbiosis is secondary to pathology. In this review, we discuss our current knowledge on the impact of gut bacteria, virome, and mycobiome interactions with the host and how they could be manipulated to promote health. Keywords: microbiome; biomarkers; personalized nutrition; microbes; metagenomics 1. Introduction The human body consists of mammalian cells and many microbial cells (bacteria, viruses, and fungi) which co-exist symbiotically.
    [Show full text]
  • Human Microbiome: Your Body Is an Ecosystem
    Human Microbiome: Your Body Is an Ecosystem This StepRead is based on an article provided by the American Museum of Natural History. What Is an Ecosystem? An ecosystem is a community of living things. The living things in an ecosystem interact with each other and with the non-living things around them. One example of an ecosystem is a forest. Every forest has a mix of living things, like plants and animals, and non-living things, like air, sunlight, rocks, and water. The mix of living and non-living things in each forest is unique. It is different from the mix of living and non-living things in any other ecosystem. You Are an Ecosystem The human body is also an ecosystem. There are trillions tiny organisms living in and on it. These organisms are known as microbes and include bacteria, viruses, and fungi. There are more of them living on just your skin right now than there are people on Earth. And there are a thousand times more than that in your gut! All the microbes in and on the human body form communities. The human body is an ecosystem. It is home to trillions of microbes. These communities are part of the ecosystem of the human Photo Credit: Gaby D’Alessandro/AMNH body. Together, all of these communities are known as the human microbiome. No two human microbiomes are the same. Because of this, you are a unique ecosystem. There is no other ecosystem like your body. Humans & Microbes Microbes have been around for more than 3.5 billion years.
    [Show full text]
  • Targeting the Microbiota-Gut-Brain Axis
    Author’s Accepted Manuscript Targeting the Microbiota-Gut-Brain Axis: Prebiotics Have Anxiolytic and Antidepressant-like Effects and Reverse the Impact of Chronic Stress in Mice“Prebiotics for Stress-Related Disorders” Aurelijus Burokas, Silvia Arboleya, Rachel D. Moloney, Veronica L. Peterson, Kiera Murphy, Gerard Clarke, Catherine Stanton, Timothy G. www.elsevier.com/locate/journal Dinan, John F. Cryan PII: S0006-3223(17)30042-2 DOI: http://dx.doi.org/10.1016/j.biopsych.2016.12.031 Reference: BPS13098 To appear in: Biological Psychiatry Cite this article as: Aurelijus Burokas, Silvia Arboleya, Rachel D. Moloney, Veronica L. Peterson, Kiera Murphy, Gerard Clarke, Catherine Stanton, Timothy G. Dinan and John F. Cryan, Targeting the Microbiota-Gut-Brain Axis: Prebiotics Have Anxiolytic and Antidepressant-like Effects and Reverse the Impact of Chronic Stress in Mice“Prebiotics for Stress-Related Disorders”, Biological Psychiatry, http://dx.doi.org/10.1016/j.biopsych.2016.12.031 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting galley proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Targeting the Microbiota-Gut-Brain Axis: Prebiotics Have Anxiolytic and Antidepressant-like Effects and Reverse the Impact of Chronic Stress in Mice Aurelijus Burokas1, Silvia Arboleya1,2*, Rachel D. Moloney1*, Veronica L.
    [Show full text]
  • Root Microbiota Assembly and Adaptive Differentiation Among European
    bioRxiv preprint doi: https://doi.org/10.1101/640623; this version posted May 17, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Root microbiota assembly and adaptive differentiation among European 2 Arabidopsis populations 3 4 Thorsten Thiergart1,7, Paloma Durán1,7, Thomas Ellis2, Ruben Garrido-Oter1,3, Eric Kemen4, Fabrice 5 Roux5, Carlos Alonso-Blanco6, Jon Ågren2,*, Paul Schulze-Lefert1,3,*, Stéphane Hacquard1,*. 6 7 1Max Planck Institute for Plant Breeding Research, 50829 Cologne, Germany 8 2Department of Ecology and Genetics, Evolutionary Biology Centre, Uppsala University, SE‐752 36 9 Uppsala, Sweden 10 3Cluster of Excellence on Plant Sciences (CEPLAS), Max Planck Institute for Plant Breeding Research, 11 50829 Cologne, Germany 12 4Department of Microbial Interactions, IMIT/ZMBP, University of Tübingen, 72076 Tübingen, 13 Germany 14 5LIPM, INRA, CNRS, Université de Toulouse, 31326 Castanet-Tolosan, France 15 6Departamento de Genética Molecular de Plantas, Centro Nacional de Biotecnología (CNB), Consejo 16 Superior de Investigaciones Científicas (CSIC), 28049 Madrid, Spain 17 7These authors contributed equally: Thorsten Thiergart, Paloma Durán 18 *e-mail: [email protected], [email protected], [email protected] 19 20 Summary 21 Factors that drive continental-scale variation in root microbiota and plant adaptation are poorly 22 understood. We monitored root-associated microbial communities in Arabidopsis thaliana and co- 23 occurring grasses at 17 European sites across three years.
    [Show full text]
  • Downloaded from 3
    Philips et al. BMC Genomics (2020) 21:402 https://doi.org/10.1186/s12864-020-06810-9 RESEARCH ARTICLE Open Access Analysis of oral microbiome from fossil human remains revealed the significant differences in virulence factors of modern and ancient Tannerella forsythia Anna Philips1, Ireneusz Stolarek1, Luiza Handschuh1, Katarzyna Nowis1, Anna Juras2, Dawid Trzciński2, Wioletta Nowaczewska3, Anna Wrzesińska4, Jan Potempa5,6 and Marek Figlerowicz1,7* Abstract Background: Recent advances in the next-generation sequencing (NGS) allowed the metagenomic analyses of DNA from many different environments and sources, including thousands of years old skeletal remains. It has been shown that most of the DNA extracted from ancient samples is microbial. There are several reports demonstrating that the considerable fraction of extracted DNA belonged to the bacteria accompanying the studied individuals before their death. Results: In this study we scanned 344 microbiomes from 1000- and 2000- year-old human teeth. The datasets originated from our previous studies on human ancient DNA (aDNA) and on microbial DNA accompanying human remains. We previously noticed that in many samples infection-related species have been identified, among them Tannerella forsythia, one of the most prevalent oral human pathogens. Samples containing sufficient amount of T. forsythia aDNA for a complete genome assembly were selected for thorough analyses. We confirmed that the T. forsythia-containing samples have higher amounts of the periodontitis-associated species than the control samples. Despites, other pathogens-derived aDNA was found in the tested samples it was too fragmented and damaged to allow any reasonable reconstruction of these bacteria genomes. The anthropological examination of ancient skulls from which the T.
    [Show full text]
  • The Human Microbiome, Diet, and Health: Workshop Summary
    This PDF is available from The National Academies Press at http://www.nap.edu/catalog.php?record_id=13522 The Human Microbiome, Diet, and Health: Workshop Summary ISBN Leslie Pray, Laura Pillsbury, and Emily Tomayko, Rapporteurs; Food 978-0-309-26585-0 Forum; Food and Nutrition Board; Institute of Medicine 181 pages 6 x 9 PAPERBACK (2013) Visit the National Academies Press online and register for... Instant access to free PDF downloads of titles from the NATIONAL ACADEMY OF SCIENCES NATIONAL ACADEMY OF ENGINEERING INSTITUTE OF MEDICINE NATIONAL RESEARCH COUNCIL 10% off print titles Custom notification of new releases in your field of interest Special offers and discounts Distribution, posting, or copying of this PDF is strictly prohibited without written permission of the National Academies Press. Unless otherwise indicated, all materials in this PDF are copyrighted by the National Academy of Sciences. Request reprint permission for this book Copyright © National Academy of Sciences. All rights reserved. The Human Microbiome, Diet, and Health: Workshop Summary Workshop Summary The Human Microbiome, Diet, and Health Leslie Pray, Laura Pillsbury, and Emily Tomayko, Rapporteurs Food Forum Food and Nutrition Board Copyright © National Academy of Sciences. All rights reserved. The Human Microbiome, Diet, and Health: Workshop Summary THE NATIONAL ACADEMIES PRESS 500 Fifth Street, NW Washington, DC 20001 NOTICE: The project that is the subject of this report was approved by the Govern- ing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineer- ing, and the Institute of Medicine. This study was supported by Contract Nos.
    [Show full text]
  • How Your Body Decides If Bacteria Are Friends Or Foes § Would You
    §How your body decides if bacteria are friends or foes § Would you: • Let you child eat food that dropped on the ground? • Let your child suck their thumbs? • Take antibiotics without knowing the true reason you are feeling sick? Humans and Microbes • Leeuwenhoek’s discovery of microorganisms in 17th century led people to suspect they might cause diseases • Robert Koch (1876) offered proof of what is now considered germ theory of disease; showed Bacillus anthracis causes anthrax • Today, we now know that most of the bacteria we associate with are not pathogens, and many are critical for our health. Bacteria Are Ubiquitous § We contact numerous microorganisms daily • Every surface on earth is covered! • Even clouds have microbes – Could play a role in seeding rain.. • Some have tremendous commercial value • Yogurts, wine, cheese, vinegar, pickles, etc. • Our bodies: • Breathe in, ingest, pick up on skin • Vast majority do not make us sick, or cause infections • Some colonize body surfaces; or slough off with dead epithelial cells • Most that are swallowed die in stomach or are eliminated in feces • Relatively few are pathogens that cause damage Microbes, Health, and Disease § Most microbes are harmless • Many are beneficial • Normal microbiota (normal flora) are organisms that routinely reside on body’s surfaces • Relationship is a balance, and some can cause disease under certain conditions-- opportunistic infections • Weaknesses in innate or adaptive defenses can leave individuals vulnerable to invasion – malnutrition, cancer, AIDS or
    [Show full text]
  • Skin Microbiome Analysis for Forensic Human Identification: What Do We Know So Far?
    microorganisms Review Skin Microbiome Analysis for Forensic Human Identification: What Do We Know So Far? Pamela Tozzo 1,*, Gabriella D’Angiolella 2 , Paola Brun 3, Ignazio Castagliuolo 3, Sarah Gino 4 and Luciana Caenazzo 1 1 Department of Molecular Medicine, Laboratory of Forensic Genetics, University of Padova, 35121 Padova, Italy; [email protected] 2 Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, 35121 Padova, Italy; [email protected] 3 Department of Molecular Medicine, Section of Microbiology, University of Padova, 35121 Padova, Italy; [email protected] (P.B.); [email protected] (I.C.) 4 Department of Health Sciences, University of Piemonte Orientale, 28100 Novara, Italy; [email protected] * Correspondence: [email protected]; Tel.: +39-0498272234 Received: 11 May 2020; Accepted: 8 June 2020; Published: 9 June 2020 Abstract: Microbiome research is a highly transdisciplinary field with a wide range of applications and methods for studying it, involving different computational approaches and models. The fact that different people host radically different microbiota highlights forensic perspectives in understanding what leads to this variation and what regulates it, in order to effectively use microbes as forensic evidence. This narrative review provides an overview of some of the main scientific works so far produced, focusing on the potentiality of using skin microbiome profiling for human identification in forensics. This review was performed following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The examined literature clearly ascertains that skin microbial communities, although personalized, vary systematically across body sites and time, with intrapersonal differences over time smaller than interpersonal ones, showing such a high degree of spatial and temporal variability that the degree and nature of this variability can constitute in itself an important parameter useful in distinguishing individuals from one another.
    [Show full text]
  • Potential Role of Microbiome in Oncogenesis, Outcome Prediction
    Oral Oncology 99 (2019) 104453 Contents lists available at ScienceDirect Oral Oncology journal homepage: www.elsevier.com/locate/oraloncology Review Potential role of microbiome in oncogenesis, outcome prediction and therapeutic targeting for head and neck cancer T ⁎ Ester Orlandia,b, , Nicola Alessandro Iacovellib, Vincenzo Tombolinic, Tiziana Rancatid, Antonella Polimenie, Loris De Ceccof, Riccardo Valdagnia,d,g, Francesca De Felicec a Department of Radiotherapy 1, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy b Department of Radiotherapy 2, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy c Department of Radiotherapy, Policlinico Umberto I, “Sapienza” University of Rome, Rome, Italy d Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy e Department of Oral and Maxillo Facial Sciences, Policlinico Umberto I, “Sapienza” University of Rome, Italy f Integrated Biology Platform, Department of Applied Research and Technology Development, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy g Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy ARTICLE INFO ABSTRACT Keywords: In the last decade, human microbiome research is rapidly growing involving several fields of clinical medicine Head and neck cancer and population health. Although the microbiome seems to be linked to all sorts of diseases, cancer has the Biomarkers biggest potential to be investigated. Microbiome Following the publication of the National Institute of Health - Human Microbiome Project (NIH-HMP), the Microbiota link between Head and Neck Cancer (HNC) and microbiome seems to be a fast-moving field in research area. Oncogenesis However, robust evidence-based literature is still quite scarce. Nevertheless the relationship between oral mi- Radiotherapy Immunotherapy crobiome and HNC could have important consequences for prevention and early detection of this type of tumors.
    [Show full text]
  • Analysis of Human Gut Microbiota Composition Associated to the Presence of Commensal and Pathogen Microorganisms in Côte D’Ivoire
    microorganisms Article Analysis of Human Gut Microbiota Composition Associated to the Presence of Commensal and Pathogen Microorganisms in Côte d’Ivoire Veronica Di Cristanziano 1,*,† , Fedja Farowski 2,3,† , Federica Berrilli 4,† , Maristella Santoro 4, David Di Cave 4, Christophe Glé 5, Martin Daeumer 6, Alexander Thielen 6, Maike Wirtz 1, Rolf Kaiser 1, Kirsten Alexandra Eberhardt 7,8 , Maria J. G. T. Vehreschild 2,3,9 and Rossella D’Alfonso 5,10 1 Institute of Virology, Faculty of Medicine and University Hospital of Cologne, University of Cologne, 50935 Cologne, Germany; [email protected] (M.W.); [email protected] (R.K.) 2 Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, University of Cologne, 50937 Cologne, Germany; [email protected] (F.F.); [email protected] (M.J.G.T.V.) 3 Department of Internal Medicine, Infectious Diseases, University Hospital Frankfurt, Goethe University Frankfurt, 60590 Frankfurt am Main, Germany 4 Department of Clinical Sciences and Translational Medicine, University of Rome Tor Vergata, 00133 Rome, Italy; [email protected] (F.B.); [email protected] (M.S.); [email protected] (D.D.C.) 5 Centre Don Orione Pour Handicapés Physiques, Bonoua BP 21, Côte d’Ivoire; [email protected] (C.G.); [email protected] (R.D.) 6 Seq-IT GmbH & Co KG, 67655 Kaiserslautern, Germany; [email protected] (M.D.); [email protected] (A.T.) Citation: Di Cristanziano, V.; 7 Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine & I. Department of Farowski, F.; Berrilli, F.; Santoro, M.; Medicine, University Medical Center Hamburg-Eppendorf, 20359 Hamburg, Germany; [email protected] Di Cave, D.; Glé, C.; Daeumer, M.; 8 Institute for Transfusion Medicine, University Medical Center Hamburg-Eppendorf, Thielen, A.; Wirtz, M.; Kaiser, R.; et al.
    [Show full text]